Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing

被引:1
|
作者
Liu, Po-Hong [1 ]
Nair, Rasmi G. [2 ,11 ]
Skinner, Celette Sugg [2 ,3 ]
Murphy, Caitlin C. [4 ]
Kim, Eric J. [2 ]
Ortiz, Cynthia [2 ]
Wang, Lei [2 ]
Hu, Ellen [2 ]
Lykken, Jacquelyn M. [2 ]
Levin, Theodore R. [5 ]
Green, Beverly B. [6 ,7 ]
Hahn, Erin E. [6 ,8 ]
Santini, Noel [1 ,9 ]
Halm, Ethan A. [10 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr, Peter Odonnell Jr Sch Publ Hlth, Dallas, TX USA
[3] Univ Texas Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA
[4] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX USA
[5] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA
[6] Kaiser Permanente Bernard J Tyson Sch Med, Dept Hlth Syst Sci, Pasadena, CA USA
[7] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA
[8] Kaiser Permanente Southern Calif, Dept Res & Evaluat, Pasadena, CA USA
[9] Parkland Hlth, Dallas, TX USA
[10] Univ Med & Dent New Jersey, Dept Med, New Brunswick, NJ USA
[11] UT Southwestern Med Ctr, Peter ODonnell Jr Sch Publ Hlth, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
关键词
SOCIETY TASK-FORCE; FOLLOW-UP; COLONOSCOPY; RECOMMENDATIONS; OUTREACH; TIME;
D O I
10.1158/1055-9965.EPI-23-0507
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Fecal immunochemical test (FIT) is an effective colorectal cancer screening modality. Little is known about prevalence, reasons, and testing after unsatisfactory FIT, or a FIT that cannot be processed by the laboratory due to inadequate stool specimen or incomplete labeling.Methods: Our retrospective cohort study examined unsatisfactory FIT among average-risk individuals aged 50-74 years in a large, integrated, safety-net health system who completed an index FIT from 2010 to 2019. We determined prevalence of unsatisfactory FIT and categorized reasons hierarchically. We used multivariable logistic regression models to identify factors associated with: (i) unsatisfactory FIT; and (ii) subsequent testing within 15 months of the unsatisfactory FIT.Results: Of 56,980 individuals completing an index FIT, 10.2% had an unsatisfactory FIT. Reasons included inadequate specimen (51%), incomplete labeling (27%), old specimen (13%), and broken/leaking container (8%). Unsatisfactory FIT was associated with being male [OR, 1.10; confidence interval (CI), 1.03-1.16], Black (OR, 1.46; CI, 1.33-1.61), Spanish speaking (OR, 1.12; CI, 1.01-1.24), on Medicaid (OR, 1.42; CI, 1.28-1.58), and received FIT by mail (OR, 2.66; CI, 2.35-3.01). Among those with an unsatisfactory FIT, fewer than half (41%) completed a subsequent test within 15 months (median, 4.4 months). Adults aged 50-54 years (OR, 1.16; CI, 1.01-1.39) and those who received FIT by mail (OR, 1.92; CI, 1.49-2.09) were more likely to complete a subsequent test.Conclusions: One in ten returned a FIT that could not be processed, mostly due to patient-related reasons. Fewer than half completed a subsequent test after unsatisfactory FIT.Impact: Screening programs should address these breakdowns such as specimen collection and labeling to improve real-world effectiveness. See related In the Spotlight, p. 183Impact: Screening programs should address these breakdowns such as specimen collection and labeling to improve real-world effectiveness. See related In the Spotlight, p. 183
引用
收藏
页码:215 / 223
页数:9
相关论文
共 50 条
  • [21] Participation and Ease of Use in Colorectal Cancer Screening: A Comparison of 2 Fecal Immunochemical Tests
    de Klerk, Clasine M.
    Wieten, Els
    van der Steen, Annemieke
    Ramakers, Christian R.
    Kuipers, Ernst J.
    Hansen, Bettina E.
    Lansdorp-Vogelaar, Iris
    Bossuyt, Patrick M.
    Spaander, Manon C. W.
    Dekker, Evelien
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (03): : 511 - 518
  • [22] Results of Fecal Immunochemical Tests for Colorectal Cancer Screening Not Affected by NSAIDs, Aspirin, or Anticoagulants
    Ebell, Mark H.
    AMERICAN FAMILY PHYSICIAN, 2020, 101 (07) : 435 - 435
  • [23] A Systematic Review on Diagnostic Test Accuracy of Fecal Immunochemical Tests for Colorectal Cancer Screening
    van Roon, Aafke H.
    van Dam, Leonie
    Arends, Lidia R.
    Zauber, Ann G.
    Young, Graeme P.
    van Ballegooijen, Marjolein
    Habbema, Dik F.
    van Leerdam, Monique E.
    Steyerberg, Ewout W.
    Kuipers, Ernst J.
    GASTROENTEROLOGY, 2014, 146 (05) : S409 - S410
  • [24] A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening
    Shapiro, Jean A.
    Bobo, Janet K.
    Church, Timothy R.
    Rex, Douglas K.
    Chovnick, Gary
    Thompson, Trevor D.
    Zauber, Ann G.
    Lieberman, David
    Levin, Theodore R.
    Joseph, Djenaba A.
    Nadel, Marion R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (11): : 1728 - 1735
  • [25] Effects of Oral Anticoagulants and Aspirin on Performance of Fecal Immunochemical Tests in Colorectal Cancer Screening
    Randel, Kristin Ranheim
    Botteri, Edoardo
    Romsta, Katrine Maria Kauczynska
    Frigstad, Svein Oskar
    Bretthauer, Michael
    Hoff, Geir
    de Lange, Thomas
    Holme, Oyvind
    GASTROENTEROLOGY, 2019, 156 (06) : 1642 - +
  • [26] Colorectal Cancer Screening: Fecal immunochemical Test or Sigmoidoscopy?
    Hofmann-Assmus, Marion
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (07): : 626 - 628
  • [27] Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
    Goede, S. Lucas
    Rabeneck, Linda
    van Ballegooijen, Marjolein
    Zauber, Ann G.
    Paszat, Lawrence F.
    Hoch, Jeffrey S.
    Yong, Jean H. E.
    Kroep, Sonja
    Tinmouth, Jill
    Lansdorp-Vogelaar, Iris
    PLOS ONE, 2017, 12 (03):
  • [28] Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield
    Bonander, Carl
    Westerberg, Marcus
    Chauca Strand, Gabriella
    Forsberg, Anna
    Stroemberg, Ulf
    JNCI CANCER SPECTRUM, 2024, 8 (03)
  • [29] Patient burden of colonoscopy after positive fecal immunochemical testing for colorectal cancer screening
    Denters, M. J.
    Deutekom, M.
    Bossuyt, P. M.
    Fockens, P.
    Dekker, E.
    ENDOSCOPY, 2013, 45 (05) : 342 - 349
  • [30] Fecal immunochemical testing for colorectal cancer and medication restrictions
    Baty, Vincent
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (06) : 1310 - 1311